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+ cells.
To examine steroid sensitivity, dexamethasone (DEX)-induced histone H4 lysine (K)5 acetylation and glucocorticoid receptor (GCR)α translocation were evaluated. DEX treatment for 6h significantly induced H4 K5 acetylation in normal CD4 + cells (p=0.001), but not in CD8 + cells. DEX responses were functionally impaired in CD8 + as compared to CD4 + cells, using MKP-1 (1h) (p=0.02) and IL-10 mRNA (24h) (p=0.004) induction as a read-out of steroidinduced transactivation. Normal DEX-induced GCRα nuclear translocation and no significant difference in GCRα and GCRβ mRNA expression were observed in both T cell types. Also, no significant difference in SRC-1, p300 and TIP60 expression was found. However, ATF2
expression was significantly lower in CD8 + compared to CD4 + cells (p=0.009). Importantly, inhibition of ATF2 expression by siRNA in CD4 + cells resulted in inhibition of DEX-induced transactivation in CD4 + cells.
The data indicates refractory steroid-induced transactivation but similar steroid-induced transrepression of CD8 + cells as compared to CD4 + cells due to decreased levels of the histone acetyltransferase ATF2.
INTRODUCTION
Currently glucocorticoids (GC)s are the most effective anti-inflammatory therapy used for treatment of chronic inflammatory and immune diseases. 1, 2 However the sensitivity to GCs varies considerably among immune cells. 1, 3, 4 For instance, clinical data demonstrates residual CD8 + T cell infiltration despite treatment with systemic GCs with more severe disease outcomes.
These cells could therefore be one of the key mediators for resistance to steroid therapy. It was found that in patients with multiple myeloma a decrease in the CD4 + /CD8 + ratio due to an increased number of HLA-DR expressing 5 and cancer germline specific CD8 + cells 6 is usually a good indicator of poor steroid response. In GC resistant cases of systemic lupus erythematosus, CD8 + T cells have been shown to be refractory to steroid-mediated apoptosis 7 and this is monitored as an indicator for the therapeutic efficacy of steroids. Relapses of multiple sclerosis are treated commonly with high-dose intravenous methylprednisolone. 8 Several independent studies have reported that steroid treatment can significantly decrease the numbers of CD4 + T cells in these patients; 8 however, the same studies observed no change or even an increase in the number of CD8 + T cells after treatment in poorly controlled patients. 9 In asthma patients a decline in lung function as an asthma outcome has been shown to correlate with the number of lung infiltrating CD8 + cells. 10 In patients with chronic obstructive pulmonary disease (COPD) it had been shown that CD8 + , CD68 + cells and neutrophils are refractory to treatment with inhaled steroids, highlighting a need for understanding differential cell response to GCs. 11, 12 GCs exert their biological effect through a specific receptor, glucocorticoid receptor α (GCRα), which is expressed in virtually all cells. GCRα is a DNA-binding protein, located in the cell cytoplasm. Its nuclear translocation is induced upon ligand binding. GCs suppress production of multiple inflammatory proteins via transrepression and transactivation. 13 GCRα directly interacts with pro-inflammatory transcription factors preventing transcription of inflammatory genes (transrepression). 1, 13, 14 Activated GCRα also directly binds to its recognition sites in the promoters of certain genes to activate their transcription (transactivation), resulting in production of anti-inflammatory proteins, such as mitogen-activated protein kinase phosphatase 
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(MKP-1), which inhibits MAP kinase signaling pathways. 15 Recently new insights have been gained into the molecular mechanisms how GCs suppress inflammation through transactivation and transrepression, 2, 13 as well the importance of histone modification in steroid responsiveness. [16] [17] [18] Several molecular mechanisms had been reported to be involved in the GC resistance, including increased expression of GCRβ. 1, 19 GCRβ is the homologous isoform of GCRα in human cells, which is generated from alternative splicing of the human GCR gene. 20 
Subjects
This study was approved by the Institutional Review Board at National Jewish Medical and Research Center, Denver, CO. Eight normal healthy adult donors with no history of atopic and respiratory diseases were enrolled in the current study. Informed consent was signed during the time of blood draw.
Isolation of human PBMC and magnetic cell sorting
PBMC were isolated by Ficoll-Hypaque  density gradient centrifugation from heparinized venous blood of healthy donors as previously described. 30 Cells were subsequently seeded to the slides to stain for acetylated histone H4 K5 or sorted into CD4 + and CD8 + T cells by negative depletion using magnetic cell sorting based on the manufacture's instructions M DEX for 1h before RNA extraction; for DEX-induced IL-10 experiments, the cells were incubated with or without 10 -7 M DEX for 24h before RNA extraction. The quantitative realtime PCR was performed as previously described. 31 Briefly, the reactions were carried out using the dual-labeled fluorigenic probe method. ABI prism 7000 sequence detector (Applied Biosystems) was used to run real-time PCR and collect fluorescence data. Relative gene expression levels were calculated and normalized to the corresponding levels of thehousekeeping gene (GADPH). Standard curves for all targets were generated using the fluorescent data from two-fold serial dilutions of 1000ng total RNA of the target sample. Standard curves for GCRα and GCRβ were generated from ten-fold serial dilutions of the GCRα and GCRβ plasmids as described by us earlier.
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GGRα nuclear translocation
GCRα intracellular translocation in response to 10 -7 M DEX (Sigma Chemical Co., St.
Louis, MO) treatment was analyzed by immunofluorescent staining. In these experiments, freshly isolated PBMC were seeded at 1×10 6 cells/ml on poly-D-lysine coated cover slips. Cells (acetylated K5) MFI before and after DEX treatment in CD4 + and CD8 + T cells.
Western blotting
Purified CD4 + and CD8 + T cells were treated with DEX (10
M, 10 -7 M) before lysis in ice-cold RIPA buffer containing protease inhibitor cocktail (Sigma). 30µg of total protein were separated by SDS-PAGE and transferred to the nitrocellulose membrane. MKP-1 was assayed using anti-MKP-1 antibody (Santa Cruz Biotechnology).
Nuclear extracts were prepared from freshly isolated CD4 + and CD8 + T cells with a NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce, Rockford, IL). 10µg of nuclear protein per condition were run on 4-15% gradient gel (Bio-Rad Laboratories, Hercules, CA) and transferred to the nitrocellulose membrane. The membranes were blotted with anti-SRC-1, ATF2
and TIP60 (Santa Cruz Biotechnology) antibodies. For p300 detection, 60µg of whole cell extracts were run on 7.5% gel (Bio-Rad Laboratories), transferred to the membrane for 4h at 20V
in the cold room. The membrane was then incubated with 2 µg/ml anti-p300 antibody (Upstate, Lake Placid, NY). To control the quality of nuclear proteins preparation the membranes were stripped and re-probed with anti-C23 antibody (Santa Cruz Biotechnology) used as nuclear control protein. 34 Developed X-ray films were scanned and densitometry of the bands was quantified using NIH Image software (v. 1.63) (this software is available on the Internet at http://rsb.info.nih.gov/nih-image).
Silencing of ATF2 expression by specific siRNA
Small interfering RNAs (siRNAs) were used to inhibit ATF2 gene expression. ATF2
siRNA, non-specific siRNA were purchased from Santa Cruz Biotechnology. Commercial
Nucleofector human T cells kit (Amaxa, Gaithenberg, MD) and special transfection program for human T cells on the Nucleofector Device (Amaxa) were used. In brief, 5×10 6 purified CD4 + T cells were suspended in 100 µl of transfection solution and transfected with 1 µg of ATF2 siRNA, or nonsilencing control siRNA using the V014 program (approach previously described by Goleva et al. 19 ). Transfected cells were immediately diluted with pre-warmed T cells growth media (Amaxa) and cultured in 24-well plates or on poly-D-lysine coated coverslips. To confirm inhibition of ATF2 mRNA and protein expression by ATF2 siRNA, transfected cells were serially assayed by real-time PCR and microscopy 24h to 72h after transfection for ATF2 expression with methods described above. To determine the effect of siRNA delivery on cell viability, the trypan blue dye exclusion test was used. The cell viability was usually 70-80% at 48h and 50-60% at 72h after siRNA transfection.
Statistical analysis
Data were expressed as mean±SEM. (Fig. 1A) .
To provide more definitive evidence regarding the divergent GCR transactivation activity or cultured in media alone. The DEX-mediated increase in MKP-1 protein level was dose dependent both in CD4 + and CD8 + T cells; however, much stronger induction of MKP-1 was observed in CD4 + than in CD8 + T cells was noted (Fig. 1C) .
DEX induces similar GCRα nuclear translocation in CD4 + and CD8 + T cells
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To determine whether the differences in GCR transactivation properties of CD4 + vs.
CD8
+ T cells were caused by the difference in GCRα nuclear translocation in response to steroids, we measured the GCRα cellular translocation in response to DEX in normal CD4 + vs. CD8 + T cells. GCRα nuclear translocation was assessed in response to 10 -7 M DEX by immunostaining. In the absence of DEX, GCRα was localized uniformly in T cells; DEX induced GCRα nuclear translocation within 1h. Increasing the time of DEX treatment for greater than 1h had no further effect on GCRα nuclear translocation, therefore we used this time point to assay additional subjects. As shown in Fig. 2A-C 
T cells. GCR was measured in nuclear extracts from these cells based on its interaction
with GRE consensus motive immobilized to the plate (TransAM GR transcription factor assay). No difference in the amount of nuclear GCR was found in freshly isolated CD4 + and CD8 + T cells. Addition of DEX to the cells resulted in a significant increase in the amount of nuclear GCR both in CD4 + and CD8 + T cells (Fig. 2D ). Both cell types showed similar amounts of nuclear GCR after DEX treatment.
Because GC anti-inflammatory response is mediated through GCRα, and alternatively spliced isoform -GCRβ, can interfere with GCRα by forming heterodimers with GCRα 33 and compete for steroid receptor coactivator 23 and GRE, 25 36 Because histone H4 K5 acetylation is a marker of GC-mediated transactivation, 17 we examined the ability of GCs to induce H4 acetylation at residue K5. Using immunostaining, we found (Fig. 4) TIP60 expression between these two cell populations was found (Fig. 5A, 5C ). We were unable to consistently detect p300 in T cell nuclear extracts from all donors, most likely due to insufficient cell amount used (6×10 6 CD4 + or CD8 + was the maximal cell number we could recover). While using whole cell extracts from CD4 + and CD8 + cells we did not detect a difference in p300 expression between these two cell types (Fig. 5B) (Fig. 5D, 5E ). The densitometry ratio of ATF2 to C23 was 0.53±0.11 in CD8 + cells as compared to 0.75±0.11 in CD4 + cells (n=8, p=0.009). (Fig. 6D ).
The effect of ATF2 gene silencing on DEX-induced gene transactivation in human CD4
This data supports the concept that ATF2, via acetylation of the histone H4 K5 residue, controls GC-mediated gene transactivation in T lymphocytes and accounts for differences in steroid responsiveness of CD8 + vs. CD4 + cells.
For M DEX (the highest physiological dose) (data not shown), suggesting that both DEX effect on the sensitivity of cells (EC50) and maximal response seen (Emax) were significantly altered in CD8 + cells as compared to CD4 + cells. These data suggested that CD8 + T cells are refractory to steroids because of a failure of steroids to switch on anti-inflammatory gene expression, rather than a failure to switch off inflammatory genes. Our data supports the idea that steroid responses can be regulated not only by GCR transrepression, but also by GCR transactivation.
Since reduced GCRα cellular translocation in response to steroids and divergent expression of GCRα vs. dominant negative isoform, GCRβ, by cells can modify cellular response to steroids, 19, 26, 27, 33 we evaluated these parameters of steroid response in our system.
There was no difference in DEX-induced GCRα nuclear translocation of CD4 + vs. CD8 + T cells.
As well, similar levels of GCRα and GCRβ mRNA were found in both cell types. 
